HempFusion Launches Private Label Business Division, Awarded 10 SKU Private Label Deal with Leading National Retailer Biotech Investing
BetterLife Pharma Appoints Henri Sant-Cassia of The Conscious Fund to its Board of Directors Company News
Phase 3 Maintenance Results Show Patients with Crohn's Disease Receiving Risankizumab Achieved Endoscopic Response and Clinical Remission at One Year Biotech Investing
Health Canada Approves OPDIVO® plus YERVOY® as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma Biotech Investing
AbbVie to Present Analysis Evaluating Continuous RINVOQ® Treatment in Psoriatic Arthritis for More Than One Year at EULAR 2021 Virtual Congress Biotech Investing
BriaCell Reports 12.0 Months Overall Survival Benefit in Advanced Breast Cancer; 100% Resolution of 'Eye-Bulging' Tumor Biotech Investing
New Long-Term Efficacy and Safety Analyses Evaluating RINVOQ® in Patients with Rheumatoid Arthritis to be Presented at EULAR 2021 Virtual Congress Biotech Investing
Bristol Myers Squibb Data at EULAR 2021 Highlight Commitment to Driving Advancements Across Multiple Immune-Mediated Rheumatic Diseases Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo Plus Yervoy as First-Line Treatment for Unresectable Malignant Pleural Mesothelioma Biotech Investing
